These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2017 related items for PubMed ID: 18693632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The future of renin inhibition].
    Uresin AY, Baran E.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [Abstract] [Full Text] [Related]

  • 6. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ, Smith SM, Choksi R.
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [Abstract] [Full Text] [Related]

  • 7. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
    Abassi Z, Winaver J, Feuerstein GZ.
    Biochem Pharmacol; 2009 Oct 15; 78(8):933-40. PubMed ID: 19477166
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A, Divchev D, Luchtefeld M, Schieffer B.
    Minerva Cardioangiol; 2009 Dec 15; 57(6):773-85. PubMed ID: 19942847
    [Abstract] [Full Text] [Related]

  • 9. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE, Julius S.
    Am Heart J; 2004 Nov 15; 148(5):747-54. PubMed ID: 15523303
    [Abstract] [Full Text] [Related]

  • 10. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM.
    Acta Diabetol; 2005 Apr 15; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Renin inhibition--benefit beyond hypertension control.
    Kher V.
    J Assoc Physicians India; 2009 Jul 15; 57():518-20, 525. PubMed ID: 20329413
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS.
    J Assoc Physicians India; 2010 Feb 15; 58():102-8. PubMed ID: 20653151
    [Abstract] [Full Text] [Related]

  • 14. Aliskiren: an oral renin inhibitor for the treatment of hypertension.
    Lam S, Choy M.
    Cardiol Rev; 2007 Feb 15; 15(6):316-23. PubMed ID: 18090068
    [Abstract] [Full Text] [Related]

  • 15. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
    Weber MA, Giles TD.
    Rev Cardiovasc Med; 2006 Feb 15; 7(2):45-54. PubMed ID: 16915123
    [Abstract] [Full Text] [Related]

  • 16. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec 15; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 17. Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.
    Estacio RO.
    Postgrad Med; 2009 May 15; 121(3):33-44. PubMed ID: 19491538
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG.
    J Indian Med Assoc; 2009 Mar 15; 107(3):178-82. PubMed ID: 19810392
    [Abstract] [Full Text] [Related]

  • 19. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
    Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec 15; 10(4):185-9. PubMed ID: 19617273
    [Abstract] [Full Text] [Related]

  • 20. Aliskiren in the treatment of hypertension and organ damage.
    Riccioni G.
    Cardiovasc Ther; 2011 Feb 15; 29(1):77-87. PubMed ID: 21106033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 101.